97 related articles for article (PubMed ID: 8678562)
21. The role of combined allelic imbalance and mutations of p53 in tumor progression and survival following surgery for colorectal carcinoma.
Lagerstedt KK; Kressner U; Lönnroth C; Nordgren S; Lundholm K
Int J Oncol; 2005 Dec; 27(6):1707-15. PubMed ID: 16273227
[TBL] [Abstract][Full Text] [Related]
22. Molecular detection of genetic alterations in the serum of colorectal cancer patients.
Hibi K; Robinson CR; Booker S; Wu L; Hamilton SR; Sidransky D; Jen J
Cancer Res; 1998 Apr; 58(7):1405-7. PubMed ID: 9537240
[TBL] [Abstract][Full Text] [Related]
23. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
24. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.
Sunahara M; Ichimiya S; Nimura Y; Takada N; Sakiyama S; Sato Y; Todo S; Adachi W; Amano J; Nakagawara A
Int J Oncol; 1998 Aug; 13(2):319-23. PubMed ID: 9664127
[TBL] [Abstract][Full Text] [Related]
26. Microsatellite instability and somatic mutations in endometrial carcinomas.
Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N
Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
28. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines.
Cottu PH; Muzeau F; Estreicher A; Fléjou JF; Iggo R; Thomas G; Hamelin R
Oncogene; 1996 Dec; 13(12):2727-30. PubMed ID: 9000147
[TBL] [Abstract][Full Text] [Related]
29. Telomeric repeat-length alterations in colorectal carcinoma are associated with loss of heterozygosity and point mutation in p53 gene.
Ohki S; Onda M; Fukushima T; Takita K; Suzuki S; Hoshino M; Tsuchiya A; Abe R; Takenoshita S
Int J Mol Med; 2003 Apr; 11(4):485-90. PubMed ID: 12632102
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite alterations on human chromosome 11 in in situ and invasive breast cancer: a microdissection microsatellite analysis and correlation with p53, ER (estrogen receptor), and PR (progesterone receptor) protein immunoreactivity.
Shen KL; Yang LS; Hsieh HF; Chen CJ; Yu JC; Tsai NM; Harn HJ
J Surg Oncol; 2000 Jun; 74(2):100-7. PubMed ID: 10914818
[TBL] [Abstract][Full Text] [Related]
31. Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas.
Young J; Leggett B; Ward M; Thomas L; Buttenshaw R; Searle J; Chenevix-Trench G
Oncogene; 1993 Mar; 8(3):671-5. PubMed ID: 8437850
[TBL] [Abstract][Full Text] [Related]
32. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
33. Alterations of (CA)n DNA repeats and tumor suppressor genes in human gastric cancer.
Mironov NM; Aguelon MA; Potapova GI; Omori Y; Gorbunov OV; Klimenkov AA; Yamasaki H
Cancer Res; 1994 Jan; 54(1):41-4. PubMed ID: 8261459
[TBL] [Abstract][Full Text] [Related]
34. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.
Carder P; Wyllie AH; Purdie CA; Morris RG; White S; Piris J; Bird CC
Oncogene; 1993 May; 8(5):1397-401. PubMed ID: 8479757
[TBL] [Abstract][Full Text] [Related]
35. 17q allele loss is associated with lymph node metastasis in locally aggressive human colorectal cancer.
Purdie CA; Piris J; Bird CC; Wyllie AH
J Pathol; 1995 Mar; 175(3):297-302. PubMed ID: 7745498
[TBL] [Abstract][Full Text] [Related]
36. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors.
Makos M; Nelkin BD; Reiter RE; Gnarra JR; Brooks J; Isaacs W; Linehan M; Baylin SB
Cancer Res; 1993 Jun; 53(12):2719-22. PubMed ID: 8504410
[TBL] [Abstract][Full Text] [Related]
37. Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.
Middeldorp A; van Eijk R; Oosting J; Forte GI; van Puijenbroek M; van Nieuwenhuizen M; Corver WE; Ruano D; Caldes T; Wijnen J; Morreau H; van Wezel T
Int J Cancer; 2012 Feb; 130(4):837-46. PubMed ID: 21445971
[TBL] [Abstract][Full Text] [Related]
38. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences.
Kim H; Jen J; Vogelstein B; Hamilton SR
Am J Pathol; 1994 Jul; 145(1):148-56. PubMed ID: 8030745
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of replication errors on chromosomes 2p and 3p in non-small-cell lung cancer.
Pifarré A; Rosell R; Monzó M; De Anta JM; Moreno I; Sánchez JJ; Ariza A; Mate JL; Martińez E; Sánchez M
Br J Cancer; 1997; 75(2):184-9. PubMed ID: 9010024
[TBL] [Abstract][Full Text] [Related]
40. Alternative genetic pathways in colorectal carcinogenesis.
Olschwang S; Hamelin R; Laurent-Puig P; Thuille B; De Rycke Y; Li YJ; Muzeau F; Girodet J; Salmon RJ; Thomas G
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):12122-7. PubMed ID: 9342373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
